Early Graft Dysfunction After Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 631-633

  Briceno J ^a   Ciria, R ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE; ASPARTATE AMINOTRANSFERASE; BETA GALACTOSIDASE; CREATININE; ENDOTHELIN 1; GELATINASE B; HEME OXYGENASE; HISTIDINE TRYPTOPHAN KETOGLUTARATE; HYALURONIC ACID; INOTROPIC AGENT; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

AFRICAN AMERICAN; AGE DISTRIBUTION; ALLOTRANSPLANTATION; ANESTHESIA; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BISPECTRAL INDEX; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY GRAFT DYSFUNCTION; ENDOTHELIUM CELL; EXTRACORPOREAL OXYGENATION; FATTY LIVER; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; HEART DEATH; HUMAN; HYPERNATREMIA; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; ITO CELL; KIDNEY TRANSPLANTATION; KUPFFER CELL; LEUKOCYTE ACTIVATION; LIVER FAILURE; LIVER FUNCTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MORTALITY; NEUTROPHIL CHEMOTAXIS; ORGAN DONOR; ORGAN PRESERVATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REOXYGENATION; REPERFUSION INJURY; RETRANSPLANTATION; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; UNDERWEIGHT;

ADULT; GRAFT SURVIVAL; HUMANS; KUPFFER CELLS; LIVER FAILURE; LIVER TRANSPLANTATION; MIDDLE AGED; REPERFUSION INJURY; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77949463523     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.004     Document Type: Article

References (21)

1. United Network of Organ Sharing (2009). www.UNOS.org
2. Silberhumer G.R., Pokorny H., Hetz H., et al. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation 83 (2007) 588
3. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant 9 (2003) 651
4. Vardanian A.J., Busuttil R.W., and Kupiec-Weglinski J.W. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med 14 (2008) 337
5. Monbaliu D.M., Pelt J., De Vos R., et al. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transplant 13 (2007) 239
6. Dahaba A.A., Feng Z.Y., Zhu S.M., et al. The utility of using bispectral index monitoring as an early intraoperative indicator of initial poor graft function after orthotopic or split-graft liver transplantation. Gut (2009) 605
7. Johnson S.R., Alexopoulos S., Curry M., et al. Primary nonfunction (PNF) in the MELD era: an SRTR database analysis. Am J Transplant 7 (2007) 1003
8. Briceño J., Padillo J., Marchal T., et al. Influence of marginal donors on liver preservation injury. Transplantation 74 (2002) 522
9. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 (2006) 783
10. Hill M.J., Hughes M., Jie T., et al. Graft weight/recipient weight ratio: how well does it predict outcome after partial liver transplants?. Liver Transplant 15 (2009) 1056
11. Pine J.K., Aldouri A., Young A.L., et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transplant 15 (2009) 1072
12. De Vera M.E., López-Solís R., Dvorchik I., et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 9 (2009) 773
13. Jiménez-Galanes S., Meneu J.C., Moreno A., et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transplant 15 (2009) 1110
14. Hong J.C., and Busuttil R.W. Cold ischemia time and liver graft survival. Am J Transplant 8 (2008) 481
15. Feng L., Zhao N., Sun X., et al. Histidine-Tryptophan-Ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transplant 13 (2007) 1125
16. Ijtsma A.J.C., van der Hilst C.S., de Boer M.T., et al. The clinical relevance of the anhepatic phase during liver transplantation. Liver Transplant 15 (2009) 1050
17. Lee K.W., Cameron A.M., Maley W.R., et al. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am J Transplant 8 (2008) 1186
18. Dick A.A.S., Spitzer A.L., Seifert C.F., et al. Liver transplantation at the extremes of the body mass index. Liver Transplant 15 (2009) 968
19. Iannou G.N. Development and validation of a model predicting graft survival after liver transplantation. Liver Transplant 12 (2006) 1594
20. Rana A., Hardy M.A., Halazun K.J., et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 8 (2008) 2537
21. Halldorson J.B., Bakthavatsalam R., Fix O., et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 9 (2009) 318